Why Cardinal Health (CAH) is a Top Growth Stock for the Long-Term

Company Overview - Cardinal Health is one of the world's largest healthcare services and products providers, operating across various segments including Pharmaceutical & Specialty Solutions and Global Medical Products & Distribution [12] - The company serves nearly 90% of U.S. hospitals and delivers over 43,000 pharmaceutical shipments daily [12] - Cardinal Health manages a broad portfolio of medical, surgical, and laboratory products, and operates nearly 130 nuclear pharmacies and 30 PET cyclotron facilities [12] Investment Ratings - Cardinal Health has a Zacks Rank of 2 (Buy) and a VGM Score of A, indicating strong potential for growth [13][14] - The company is particularly appealing for growth investors, with a Growth Style Score of A and a forecasted year-over-year earnings growth of 14.2% for the current fiscal year [13] Earnings Estimates - Seven analysts have revised their earnings estimates upwards in the last 60 days for fiscal 2026, with the Zacks Consensus Estimate increasing by $0.20 to $9.41 per share [13] - Cardinal Health boasts an average earnings surprise of +9.2%, further indicating its strong performance potential [13]